303 related articles for article (PubMed ID: 17005826)
1. Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.
Joska TM; Anderson AC
Antimicrob Agents Chemother; 2006 Oct; 50(10):3435-43. PubMed ID: 17005826
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis.
Nammalwar B; Bunce RA; Berlin KD; Bourne CR; Bourne PC; Barrow EW; Barrow WW
Eur J Med Chem; 2012 Aug; 54():387-96. PubMed ID: 22703705
[TBL] [Abstract][Full Text] [Related]
4. Polysaccharide deacetylases serve as new targets for the design of inhibitors against Bacillus anthracis and Bacillus cereus.
Balomenou S; Koutsioulis D; Tomatsidou A; Tzanodaskalaki M; Petratos K; Bouriotis V
Bioorg Med Chem; 2018 Jul; 26(13):3845-3851. PubMed ID: 29983281
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidines.
Nammalwar B; Bourne CR; Bunce RA; Wakeham N; Bourne PC; Ramnarayan K; Mylvaganam S; Berlin KD; Barrow EW; Barrow WW
ChemMedChem; 2012 Nov; 7(11):1974-82. PubMed ID: 22930550
[TBL] [Abstract][Full Text] [Related]
6. Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracis.
Nammalwar B; Bourne CR; Wakeham N; Bourne PC; Barrow EW; Muddala NP; Bunce RA; Berlin KD; Barrow WW
Bioorg Med Chem; 2015 Jan; 23(1):203-11. PubMed ID: 25435253
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling toward selective inhibitors of dihydrofolate reductase from the biological warfare agent Bacillus anthracis.
Giacoppo JO; Mancini DT; Guimarães AP; Gonçalves AS; da Cunha EF; França TC; Ramalho TC
Eur J Med Chem; 2015 Feb; 91():63-71. PubMed ID: 24985033
[TBL] [Abstract][Full Text] [Related]
8. Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis.
Gustafsson TN; Osman H; Werngren J; Hoffner S; Engman L; Holmgren A
Biochim Biophys Acta; 2016 Jun; 1860(6):1265-71. PubMed ID: 26971857
[TBL] [Abstract][Full Text] [Related]
9. Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase.
Beierlein JM; Frey KM; Bolstad DB; Pelphrey PM; Joska TM; Smith AE; Priestley ND; Wright DL; Anderson AC
J Med Chem; 2008 Dec; 51(23):7532-40. PubMed ID: 19007108
[TBL] [Abstract][Full Text] [Related]
10. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim.
Barrow EW; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4643-9. PubMed ID: 15561838
[TBL] [Abstract][Full Text] [Related]
11. The solution structure of Bacillus anthracis dihydrofolate reductase yields insight into the analysis of structure-activity relationships for novel inhibitors.
Beierlein JM; Deshmukh L; Frey KM; Vinogradova O; Anderson AC
Biochemistry; 2009 May; 48(19):4100-8. PubMed ID: 19323450
[TBL] [Abstract][Full Text] [Related]
12. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase.
Bourne CR; Wakeham N; Nammalwar B; Tseitin V; Bourne PC; Barrow EW; Mylvaganam S; Ramnarayan K; Bunce RA; Berlin KD; Barrow WW
Biochim Biophys Acta; 2013 Jan; 1834(1):46-52. PubMed ID: 22999981
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity.
Bourne CR; Bunce RA; Bourne PC; Berlin KD; Barrow EW; Barrow WW
Antimicrob Agents Chemother; 2009 Jul; 53(7):3065-73. PubMed ID: 19364848
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
Bennett BC; Xu H; Simmerman RF; Lee RE; Dealwis CG
J Med Chem; 2007 Sep; 50(18):4374-81. PubMed ID: 17696333
[TBL] [Abstract][Full Text] [Related]
17. Targeted mutations of Bacillus anthracis dihydrofolate reductase condense complex structure−activity relationships.
Beierlein JM; Karri NG; Anderson AC
J Med Chem; 2010 Oct; 53(20):7327-36. PubMed ID: 20882962
[TBL] [Abstract][Full Text] [Related]
18. The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling.
Hong W; Wang Y; Chang Z; Yang Y; Pu J; Sun T; Kaur S; Sacchettini JC; Jung H; Lin Wong W; Fah Yap L; Fong Ngeow Y; Paterson IC; Wang H
Sci Rep; 2015 Oct; 5():15328. PubMed ID: 26471125
[TBL] [Abstract][Full Text] [Related]
19. Dicyclic and tricyclic diaminopyrimidine derivatives as potent inhibitors of Cryptosporidium parvum dihydrofolate reductase: structure-activity and structure-selectivity correlations.
Nelson RG; Rosowsky A
Antimicrob Agents Chemother; 2001 Dec; 45(12):3293-303. PubMed ID: 11709300
[TBL] [Abstract][Full Text] [Related]
20. New small-molecule inhibitors of dihydrofolate reductase inhibit Streptococcus mutans.
Zhang Q; Nguyen T; McMichael M; Velu SE; Zou J; Zhou X; Wu H
Int J Antimicrob Agents; 2015 Aug; 46(2):174-82. PubMed ID: 26022931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
